دورية أكاديمية
Self-Retained, Sutureless Amniotic Membrane Transplantation for the Management of Ocular Surface Diseases.
العنوان: | Self-Retained, Sutureless Amniotic Membrane Transplantation for the Management of Ocular Surface Diseases. |
---|---|
المؤلفون: | Chiu HI; Department of Ophthalmology, Taipei Veterans General Hospital, Taipei 112, Taiwan., Tsai CC; Department of Ophthalmology, Taipei Veterans General Hospital, Taipei 112, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan. |
المصدر: | Journal of clinical medicine [J Clin Med] 2023 Sep 27; Vol. 12 (19). Date of Electronic Publication: 2023 Sep 27. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI AG, [2012]- |
مستخلص: | Amniotic membrane (AM) has anti-inflammation, anti-fibrotic, and regenerative effects. Sutureless cryopreserved AM transplantation, ProKera ® (Bio-Tissue, Inc., Miami, FL, USA), is easily applied by ophthalmologists in the treatment of ocular surface diseases. This retrospective study included patients with ocular surface diseases who received ProKera ® between January 2022 and May 2023. Six patients (9 eyes) with a mean age of 56.8 ± 20.8 years old (range 25-74) and a mean follow-up period of 7.8 ± 4.1 months (range 1-12) were included, including 2 of recurrent conjunctival tumors with limbal and corneal involvement (cases 1-2), 1 of pterygium with marked astigmatism (case 3) and 3 of Stevens-Johnson syndrome (SJS, cases 4-6). ProKera ® was inserted after the lesion excision and deep keratectomy in cases 1-3, and no recurrence or corneal complication was noted. Cases 4-5 were discharged from the intensive care unit and presented with severe chronic SJS. Most ocular manifestations improved significantly after symblepharon release and ProKera ® insertion, except for corneal conjunctivalization in 1 eye (case 5). Case 6 involved early ProKera ® use at the bedside during acute SJS, resulting in complete resolution. We concluded that the adjunctive application of ProKera ® can be effective for ocular surface reconstruction and provides options to intervene earlier for outpatients or patients unstable for invasive surgical intervention. |
References: | Semin Ophthalmol. 2016;31(1-2):178-87. (PMID: 26959145) Arq Bras Oftalmol. 2017 Jul-Aug;80(4):242-246. (PMID: 28954025) BMC Ophthalmol. 2016 Jul 18;16:111. (PMID: 27430523) Eye Contact Lens. 2012 Jul;38(4):266-7. (PMID: 22169879) Cornea. 2022 Jul 1;41(7):840-844. (PMID: 34483269) J Cataract Refract Surg. 2006 Jan;32(1):162-5. (PMID: 16516797) Eur J Ophthalmol. 2011 Sep-Oct;21(5):552-8. (PMID: 21188684) Ophthalmology. 2016 Aug;123(8):1653-1658. (PMID: 27297404) Curr Opin Ophthalmol. 2016 Nov;27(6):522-529. (PMID: 27585215) Graefes Arch Clin Exp Ophthalmol. 2000 Jan;238(1):68-75. (PMID: 10664056) Br J Ophthalmol. 2000 Sep;84(9):973-8. (PMID: 10966947) Br J Ophthalmol. 2018 Nov;102(11):1602-1606. (PMID: 30100555) Dtsch Arztebl Int. 2011 Apr;108(14):243-8. (PMID: 21547164) Br J Ophthalmol. 2001 Apr;85(4):444-9. (PMID: 11264135) Cornea. 2012 Dec;31(12):1394-402. (PMID: 23135531) Taiwan J Ophthalmol. 2021 Jun 02;11(2):132-140. (PMID: 34295618) Curr Eye Res. 2000 Mar;20(3):173-7. (PMID: 10694891) Graefes Arch Clin Exp Ophthalmol. 2011 Feb;249(2):261-5. (PMID: 20821228) J Cell Physiol. 1999 Jun;179(3):325-35. (PMID: 10228951) Ophthalmology. 2016 Mar;123(3):484-91. (PMID: 26686968) J Pediatr Ophthalmol Strabismus. 2012 Mar-Apr;49(2):114-9. (PMID: 21877676) Ocul Surf. 2020 Jul;18(3):517-522. (PMID: 32200005) J Clin Med. 2021 Jul 22;10(15):. (PMID: 34362018) |
معلومات مُعتمدة: | V112-C-054 Taipei Veterans General Hospital |
فهرسة مساهمة: | Keywords: ProKera®; amniotic membrane transplantation; cornea surface disease; cryopreserved; non-ophthalmologist |
تواريخ الأحداث: | Date Created: 20231014 Latest Revision: 20231031 |
رمز التحديث: | 20231215 |
مُعرف محوري في PubMed: | PMC10573988 |
DOI: | 10.3390/jcm12196222 |
PMID: | 37834866 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2077-0383 |
---|---|
DOI: | 10.3390/jcm12196222 |